Open AccessTherapeutic Potential of Ayush 64 in Covid-19: An Ayurvedic Perspective
Author(s) -
Balaji Potbhare
Publication year - 2021
Publication title -
ayurlog: national journal of research in ayurveda science
Language(s) - English
Resource type - Journals
ISSN - 2320-7329
DOI - 10.52482/ayurlog.v9i02.829
Subject(s) - traditional medicine , medicine , covid-19 , siddha , christian ministry , drug , pandemic , ayurvedic medicine , intensive care medicine , disease , pharmacology , infectious disease (medical specialty) , philosophy , theology
In the human history, a medical emergency has emerged in the form of Covid-19 disease. Coronavirus disease 2019 (COVID-19), is caused by severe acute respiratory syndrome which has become pandemic. The medical treatment of Covid-19 consists of symptomatic management and oxygen supply, with ventilation for patients with acute respiratory failure. There is no specific treatment for Covid-19. Globally, efforts are being made to verify the efficacy of traditional system of medicines to fight against the Covid-19. Ayurveda, the traditional system of Indian medicine, has also number of herbal medicines which can be used to treat the systems of Covid-19. The Ayush-64 drug is used to treat Malaria (Visama Jvara) and it has been developed by CCRAS, Ministry of AYUSH, Govt. of India. Contents of Ayush 64 drug are: Saptaparna (Alstonia scholaris R. Br.) Bark Aqueous Extract 100 mg; Katuki (Picrorhiza kurroa Royle ex. Benth) Root do 100 mg; Kirata tikta (Swertia Chirata (Pexb ex. Karst) Whole plant do 100 mg; and Kaberuka (Caesalpinia crista Linn.) Seed powder 200 mg. This paper intends to understand the drug actions of contents of Ayush 64 according to Ayurvedic point of view.